Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
Resilience and Lilly expand strategic partnership first established in 2023 Investment will significantly increase U.S. production of Lilly’s...
News (25 Test)
Read on
Resilience Announces Relocation of West Coast Headquarters to Ohio and Expansion of Sterile Manufacturing Capabilities
BLUE ASH, Ohio, June 18, 2026 – Resilience, along with Ohio Governor Mike DeWine, JobsOhio, the City of Blue Ash, and REDI Cincinnati, today...
Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy
New Capital from Oak Hill Advisors to Drive Investment in Go-Forward Manufacturing Operations CINCINNATI--(BUSINESS WIRE)--National Resilience...
Resilience and JobsOhio Announce Continued Partnership and Expansion in Blue Ash
San Diego, CA & Cincinnati, OH – March 26, 2025 – National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to...
Resilience is proud to support CARGO Therapeutics' novel allogeneic CAR-T cell therapy
SAN CARLOS, Calif., Jan. 10, 2025 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (NASDAQ: CRGX), a clinical-stage biotechnology company positioned to...
Resilience Partners with Parvus Therapeutics for Development and Manufacturing of PVT401, a Novel Autoimmune Drug Candidate for IBD
San Diego, CA – January 8, 2025 – National Resilience, Inc. (Resilience), a technology-driven biomanufacturing leader dedicated to broadening access...
